T
Timothy J. Craig
Researcher at Pennsylvania State University
Publications - 493
Citations - 21287
Timothy J. Craig is an academic researcher from Pennsylvania State University. The author has contributed to research in topics: Hereditary angioedema & Asthma. The author has an hindex of 69, co-authored 458 publications receiving 18340 citations. Previous affiliations of Timothy J. Craig include University of Bristol & San Diego State University.
Papers
More filters
Journal ArticleDOI
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.
Torsten Zuberbier,Werner Aberer,Riccardo Asero,A H Abdul Latiff,Diane Baker,Barbara Ballmer-Weber,Jonathan A. Bernstein,Carsten Bindslev-Jensen,Zenon Brzoza,R Buense Bedrikow,G.W. Canonica,Martin K. Church,Timothy J. Craig,I V Danilycheva,Corinna Dressler,Luis Felipe Ensina,Ana Giménez-Arnau,Kiran Godse,Margarida Gonçalo,Clive Grattan,Jacques Hébert,Michihiro Hide,Allen P. Kaplan,Alexander Kapp,C. Katelaris,Emek Kocatürk,Kanokvalai Kulthanan,D. Larenas-Linnemann,Tabi A. Leslie,Markus Magerl,P. Mathelier-Fusade,R. Y. Meshkova,Martin Metz,Alexander Nast,Eustachio Nettis,Hanneke Oude-Elberink,Stefanie Rosumeck,Sarbjit S. Saini,Mario Sánchez-Borges,Peter Schmid-Grendelmeier,Petra Staubach,Gordon Sussman,Elias Toubi,Gino A. Vena,Christian Vestergaard,Bettina Wedi,Ricardo Niklas Werner,Zuotao Zhao,Marcus Maurer +48 more
TL;DR: In this paper, an evidence-and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group.
Journal ArticleDOI
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial
Elliot Israel,Vernon M. Chinchilli,Jean G. Ford,Homer A. Boushey,Reuben M. Cherniack,Timothy J. Craig,Aaron Deykin,Joanne K. Fagan,John V. Fahy,James E. Fish,Monica Kraft,Susan J. Kunselman,Stephen C. Lazarus,Robert F. Lemanske,Stephen B. Liggett,Richard J. Martin,Nandita Mitra,Stephen P. Peters,Eric S. Silverman,Christine A. Sorkness,Stanley J. Szefler,Michael E. Wechsler,Scott T. Weiss,Jeffrey M. Drazen +23 more
TL;DR: Genotype at the 16th aminoacid residue of the beta2-adrenergic receptor affects the long-term response to albuterol use and Bronchodilator treatments avoiding albutersol may be appropriate for patients with the Arg/Arg genotype.
Journal ArticleDOI
Significant variability in response to inhaled corticosteroids for persistent asthma
Stanley J. Szefler,Richard J. Martin,Tonya Sharp King,Homer A. Boushey,Reuben M. Cherniack,Vernon M. Chinchilli,Timothy J. Craig,Myrna Dolovich,Jeffrey M. Drazen,Joanne K. Fagan,John V. Fahy,John V. Fahy,James E. Fish,Jean G. Ford,Elliot Israel,James P. Kiley,Monica Kraft,Stephen C. Lazarus,Robert F. Lemanske,Elizabeth A. Mauger,Stephen P. Peters,Christine A. Sorkness +21 more
TL;DR: It is possible that higher doses of ICSs are necessary to manage more severe patients or to achieve goals of therapy not evaluated in this study, such as prevention of asthma exacerbations, after a 24-week, parallel, open-label, multicenter trial.
Journal ArticleDOI
2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema
Tom Bowen,Marco Cicardi,Henriette Farkas,Konrad Bork,Hilary Longhurst,Bruce L. Zuraw,Emel Aygoeren‐Pürsün,Timothy J. Craig,Karen Binkley,Jacques Hébert,Bruce Ritchie,Laurence Bouillet,Stephen Betschel,Della Cogar,John M. Dean,Ramachand Devaraj,Azza Hamed,Palinder Kamra,Paul K. Keith,Gina Lacuesta,Eric Leith,Harriet Lyons,Sean R. Mace,Barbara Mako,Doris Neurath,Man-Chiu Poon,Georges-Etienne Rivard,R. Robert Schellenberg,Dereth Rowan,Anne Rowe,Donald Stark,Smeeksha Sur,Ellie Tsai,Richard Warrington,Susan Waserman,Rohan Ameratunga,Jonathan A. Bernstein,Janne Björkander,Kristylea Brosz,John Brosz,Anette Bygum,Teresa Caballero,Michael M. Frank,George Füst,George Harmat,Amin Kanani,Wolfhart Kreuz,Marcel Levi,Henry Li,Inmaculada Martinez-Saguer,Dumitru Moldovan,István Nagy,Erik Waage Nielsen,Patrik Nordenfelt,Avner Reshef,E. Rusicke,Sarah Smith-Foltz,Peter J. Späth,Lilian Varga,Zhi Yu Xiang +59 more
TL;DR: Consensus approach is only an interim guide to a complex disorder such as HAE and should be replaced as soon as possible with large phase III and IV clinical trials, meta analyses, and using data base registry validation of approaches.
Journal ArticleDOI
The diagnosis and management of acute and chronic urticaria: 2014 update.
Jonathan A. Bernstein,David M. Lang,David A. Khan,Timothy J. Craig,David H. Dreyfus,Fred H. Hsieh,Javed Sheikh,David Weldon,Bruce L. Zuraw,David I. Bernstein,Joann Blessing-Moore,Linda Cox,Richard A. Nicklas,John Oppenheimer,Jay M. Portnoy,Christopher Randolph,Diane E. Schuller,Sheldon L. Spector,Stephen A. Tilles,Dana Wallace +19 more
TL;DR: These parameters were developed by the Joint Task Force on Practice Parameters (JTFPP), representing the American Academy of Allergy, Asthma & Immunology, representing the AAAAI, the ACAAI, and the Joint Council of All allergy, asthma and Immunology.